William F. Doyle - Insider Trading & Ownership

Summary
The estimated net worth of William F. Doyle is at least $9.5M dollars as of June 2, 2025. William F. Doyle is the Executive Chairman, Director of NovoCure Ltd and owns shares of NovoCure Ltd (NVCR) stock worth about $8.09M. William F. Doyle is the Director of Elanco Animal Health Inc and owns shares of Elanco Animal Health Inc (ELAN) stock worth about $1.4M.
Signature
/s/ Todd Girolamo, attorney in fact
All Insider Reports
All Insider Reports

Ownership of William F. Doyle

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NVCR NovoCure Ltd Executive Chairman, Director $8.09M Aug 2, 2022
ELAN Elanco Animal Health Inc Director $1.4M Nov 29, 2024
NERV Minerva Neurosciences, Inc. Director Jun 10, 2022
PROK PROKIDNEY CORP. Director May 29, 2025

Insider Transactions Reported by William F. Doyle:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.